Cash from Investing (TTM) Chart

View Cash from Investing (TTM) for IRIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (TTM) Chart
Start Trial

Historical Cash from Investing (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 -0.233M
December 31, 2025 -0.143M
September 30, 2025 -0.046M
June 30, 2025 -0.034M
March 31, 2025 -0.021M
December 31, 2024 -0.013M
September 30, 2024 0.028M
June 30, 2024 -0.053M
March 31, 2024 -0.069M
December 31, 2023 -0.109M
September 30, 2023 -0.224M
June 30, 2023 -0.199M
March 31, 2023 -0.303M
December 31, 2022 -0.286M
September 30, 2022 -0.24M
June 30, 2022 -0.234M
March 31, 2022 -0.166M
December 31, 2021 -5.556M
September 30, 2021 -5.528M
June 30, 2021 -5.482M
March 31, 2021 -5.441M
December 31, 2020 -0.093M
September 30, 2020 -0.15M
June 30, 2020 -0.278M
March 31, 2020 -0.414M
Date Value
December 31, 2019 -0.509M
September 30, 2019 -0.577M
June 30, 2019 -0.577M
March 31, 2019 -0.624M
December 31, 2018 -0.827M
September 30, 2018 -0.816M
June 30, 2018 -0.728M
March 31, 2018 -0.723M
December 31, 2017 -0.782M
September 30, 2017 -1.022M
June 30, 2017 -1.525M
March 31, 2017 -1.708M
December 31, 2016 -1.468M
September 30, 2016 -1.344M
June 30, 2016 -1.031M
March 31, 2016 -0.99M
December 31, 2015 -1.298M
September 30, 2015 -1.253M
June 30, 2015 -1.243M
March 31, 2015 -1.318M
December 31, 2014 -1.027M
September 30, 2014 -1.074M
June 30, 2014 -1.101M
March 31, 2014 -0.354M
December 31, 2013 -0.253M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

View Cash from Investing (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (TTM) Benchmarks

View Cash from Investing (TTM) Benchmarks
Start Trial
Abbott Laboratories -22.28B
Align Technology, Inc. -218.74M
AngioDynamics, Inc. -7.302M
Accuray, Inc. -14.33M
Alphatec Holdings, Inc. -61.69M